Company Filing History:
Years Active: 2012
Title: Joseph Michael Sheridan: Innovator in Serotonergic Modulation
Introduction
Joseph Michael Sheridan is a notable inventor based in Newton, GB. He has made significant contributions to the field of pharmacology, particularly in the development of serotonergic modulators. His work focuses on innovative compounds that have the potential to impact the treatment of various conditions associated with serotonin action.
Latest Patents
Joseph Michael Sheridan holds a patent for "1, 2, 4-triazole derivatives as serotonergic modulators." This invention relates to novel 5-hydroxytryptamine (5-HT) receptor modulator compounds, which are defined by specific chemical formulas. The patent outlines the pharmaceutical compositions comprising these compounds and their applications in treating conditions linked to 5-HT action.
Career Highlights
Sheridan is associated with Prosarix Limited, where he applies his expertise in drug development and innovation. His work at the company emphasizes the importance of creating effective therapeutic agents that can enhance patient outcomes.
Collaborations
Throughout his career, Joseph Michael Sheridan has collaborated with esteemed colleagues, including Jonathan Richard Heal and William Dennys Ormrod Hamilton. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Joseph Michael Sheridan's contributions to the field of serotonergic modulation exemplify the impact of innovative thinking in pharmacology. His patent